Attached files

file filename
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) AS ADOPTED PURSUANT TO SECTION 3 - UTAH MEDICAL PRODUCTS INCexh31_1.htm
10-K - 10K - UTAH MEDICAL PRODUCTS INCutahmedical.htm
EX-32.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. ?1350, AS ADO - UTAH MEDICAL PRODUCTS INCexh32_2.htm
EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) AS ADOPT - UTAH MEDICAL PRODUCTS INCexh31_2.htm
EX-23.2 - CONSENT OF THE NORTON PRACTICE, FEMCARE GROUP LIMITED'S INDEPENDENT AUDITORS FOR - UTAH MEDICAL PRODUCTS INCexh23_2.htm
EX-23.1 - CONSENT OF JONES SIMKINS LLC, COMPANY'S INDEPENDENT AUDITORS FOR THE YEARS ENDED - UTAH MEDICAL PRODUCTS INCexh23_1.htm
EX-21.1 - SUBSIDIARIES OF UTAH MEDICAL PRODUCTS, INC. - UTAH MEDICAL PRODUCTS INCexh21_1.htm
EX-10.5 - SUMMARY OF OFFICER AND DIRECTOR COMPENSATION - UTAH MEDICAL PRODUCTS INCexh10_5.htm
Exhibit 32.1

EXHIBIT 17

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Utah Medical Products, Inc. (the "Company") on Form 10-K for the fiscal year ending December 31, 2016, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Kevin L. Cornwell, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

(1)
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.


/s/ Kevin L. Cornwell
Kevin L. Cornwell
Chief Executive Officer
March 7, 2017

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.